awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35583816-B5DC1528-B456-4234-A0DB-D977675B36F0
Q35583816-B5DC1528-B456-4234-A0DB-D977675B36F0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35583816-B5DC1528-B456-4234-A0DB-D977675B36F0
Approval summary: erlotinib maintenance therapy of advanced/metastatic non-small cell lung cancer (NSCLC)
P2860
Q35583816-B5DC1528-B456-4234-A0DB-D977675B36F0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35583816-B5DC1528-B456-4234-A0DB-D977675B36F0
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
149a32ec0084f681a874f9a050d3795be345a8ca
P2860
FDA drug approval summary: bevacizumab (Avastin) plus Carboplatin and Paclitaxel as first-line treatment of advanced/metastatic recurrent nonsquamous non-small cell lung cancer.